Read on Twitter
One has to do this 
every few years
Here is a thread about what to expect if you follow me
No surprises;
These are the topics I love to discuss (here), and in the thread, a rough outline of my views/ philosophy
[Thread]
![One has to do this every few yearsHere is a thread about what to expect if you follow meNo surprises; These are the topics I love to discuss (here), and in the thread, a rough outline of my views/ philosophy[Thread]](https://pbs.twimg.com/media/EqglzDHUwAA_lIc.jpg "One has to do this every few yearsHere is a thread about what to expect if you follow meNo surprises; These are the topics I love to discuss (here), and in the thread, a rough outline of my views/ philosophy[Thread]")
every few yearsHere is a thread about what to expect if you follow me
No surprises;
These are the topics I love to discuss (here), and in the thread, a rough outline of my views/ philosophy
[Thread]
1. But first, Who am I?
I use social media to discuss professional interests (v. rarely bicycling)
This is basically by background
@Plenary_Session is the podcast
I use social media to discuss professional interests (v. rarely bicycling)
This is basically by background
@Plenary_Session is the podcast
2. My principal interest is cancer therapies, screening & low value medical care (all domains)
My views are generally these:
My views are generally these:
3. When it comes to cancer screening
These are roughly my views, and from one you can deduce what I think about Grail, and how I will hold them accountable if they try to deploy without adequate RCT
These are roughly my views, and from one you can deduce what I think about Grail, and how I will hold them accountable if they try to deploy without adequate RCT
4. Observational studies, causal inference, the role of randomization, etc.
I am interested in thinking about these issues; this is a rough guide to my thinking...
I am interested in thinking about these issues; this is a rough guide to my thinking...
5. Regulatory approval & payment mechanisms is a major theme of my work, and the book Malignant
6. EBM - I prefer 'rational decision making' as a term, but I am interested in the messy path from clinical trials and observational studies to medical decisions
Have worked in this space for 10 years
Have worked in this space for 10 years
7. Science, the process, the people.
I am very interested and invested in working with trainees in my science
Longer thread on that topic here: https://twitter.com/VPrasadMDMPH/status/1341953451710791680?s=20
I am very interested and invested in working with trainees in my science
Longer thread on that topic here: https://twitter.com/VPrasadMDMPH/status/1341953451710791680?s=20
7 cont. I am interested in thinking about publishing, funding, promotion, tenure, and the nature of science itself
I had some fun recently with this thread on that topic https://twitter.com/VPrasadMDMPH/status/1343243517812826112?s=20
I had some fun recently with this thread on that topic https://twitter.com/VPrasadMDMPH/status/1343243517812826112?s=20
8. Argument. I am very interested in proper argument
& I am pro-debate
The biggest errors I see on this website are ad-hominem and not accurately characterizing your opponents position (the latter is omnipresent)
& I am pro-debate
The biggest errors I see on this website are ad-hominem and not accurately characterizing your opponents position (the latter is omnipresent)
8. cont. I support retraction, but not 3rd party deletion
I am not comfortable with outsourcing scientific debates to the adjudication of employees of tech companies
I am critical of mob behavior, detailed below
I am not comfortable with outsourcing scientific debates to the adjudication of employees of tech companies
I am critical of mob behavior, detailed below
9. Media coverage of science.
I am super, super interested in this topic. How do we cover science and medicine?
Here is a story about a project we did in this space https://www.npr.org/sections/health-shots/2015/10/29/452610534/if-a-new-cancer-drugs-hailed-as-a-breakthrough-odds-are-its-not
I am super, super interested in this topic. How do we cover science and medicine?
Here is a story about a project we did in this space https://www.npr.org/sections/health-shots/2015/10/29/452610534/if-a-new-cancer-drugs-hailed-as-a-breakthrough-odds-are-its-not
I'm fascinated by the fair way to represent science. We want to show the scientific method and not mislead folsk that science is a set of facts.
Anecdotes are powerful, but I prefer to change minds with data, so I struggle with anecdotes in media coverage of science.
Anecdotes are powerful, but I prefer to change minds with data, so I struggle with anecdotes in media coverage of science.
10. Social media and the academy
Although I continue to prefer journals for many types of projects, I am fascinated by social media and how it intersects with scholarship & the academy
Probably the best thing I do is this podcast: https://itunes.apple.com/us/podcast/plenary-session/id1429998903?mt=2
Although I continue to prefer journals for many types of projects, I am fascinated by social media and how it intersects with scholarship & the academy
Probably the best thing I do is this podcast: https://itunes.apple.com/us/podcast/plenary-session/id1429998903?mt=2
I also run this Youtube channel, but it is a work in progress. I try to post my lecture videos.
https://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
I have other ideas I am working on!
https://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
I have other ideas I am working on!
11. Like everyone on earth, I have been interested in COVID
This thread is everything I have written or said on the topic in long form. There are many subtopics that I have not reached a firm conclusion on and you will not find me commenting https://twitter.com/VPrasadMDMPH/status/1332349435997679622?s=20
This thread is everything I have written or said on the topic in long form. There are many subtopics that I have not reached a firm conclusion on and you will not find me commenting https://twitter.com/VPrasadMDMPH/status/1332349435997679622?s=20
